GENETIC CHEMISTRY

What this means for you

This application is over — abandoned 31 Jan 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

98327493

Mark type

Stylized text

Filed

22 Dec 2023

Abandoned

31 Jan 2025

Attorney of record

Christina M. Licursi

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceuticals, namely, pharmaceutical preparations for treatment of cancer, inflammatory diseases and disorders, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders; therapeutics in the nature of oral products, injectables, topical products, inhalation products, ophthalmic products, otic products, nasal products, rectal products, vaginal products, implants, infusions, transdermal systems, and oral thin films; therapeutic pharmaceuticals for the treatment of cancer, inflammatory diseases and disorders, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders
• Class 042 — Scientific and technological services: Pharmaceutical research and development; scientific and medical research and development; technical scientific research consultation and product development for others in the field of biotechnology and the development of pharmaceuticals and microbial products; research and development in the field of computational biology, bioinformatics, genomics, biotechnology, pharmaceuticals, and microbial products; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology, pharmaceuticals, and microbial products; drug discovery platform

Owner

• Empress Therapeutics, Inc., Cambridge, MA, US

Prosecution history

• 15 Feb 2025 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
• 15 Feb 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
• 30 Oct 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED
• 30 Oct 2024 — FINAL REFUSAL E-MAILED
• 30 Oct 2024 — FINAL REFUSAL WRITTEN
• 28 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 28 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 28 Oct 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 28 Jul 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 28 Jul 2024 — NON-FINAL ACTION E-MAILED
• 28 Jul 2024 — NON-FINAL ACTION WRITTEN
• 24 Jul 2024 — ASSIGNED TO EXAMINER
• 04 Apr 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 22 Dec 2023 — NEW APPLICATION ENTERED